Investors in Ascendis Pharma A/S (ASND) saw new options for March 2026 begin trading today, with notable contracts attracting interest. A put option at a $210.00 strike price has a current bid of $20.00, which would yield a cost basis of $190.00 if sold-to-open, representing a potential 9.52% return on investment or 35.49% annualized if it expires worthless. Current data suggests there’s a 56% chance this put could expire without value.
On the calls side, a $220.00 strike price call has a bid of $16.50. An investor purchasing shares at $213.19 and writing this call could see a total return of 10.93% if the stock is called away at expiration. There’s a 51% chance this call will also expire worthless, allowing the investor to keep the premium collected. Both contracts exhibit an implied volatility of approximately 53%.
